Answer
Yes, severe pneumonitis or interstitial lung disease, including fatal cases, has been observed with ipilimumab (Yervoy) in combination with nivolumab.
Sources for this answer
- YERVOY 5 mg/ml concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 46Document updated
Sources checked